IRIS
DE VINCENTIS, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.414
NA - Nord America 1.612
EU - Europa 821
SA - Sud America 282
AF - Africa 48
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.190
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 4.263
US - Stati Uniti d'America 1.550
CN - Cina 571
IT - Italia 396
HK - Hong Kong 272
BR - Brasile 206
VN - Vietnam 121
FR - Francia 113
GB - Regno Unito 98
DE - Germania 67
IN - India 50
MX - Messico 33
AR - Argentina 31
NL - Olanda 29
CA - Canada 25
FI - Finlandia 19
PL - Polonia 18
TR - Turchia 18
CZ - Repubblica Ceca 17
ID - Indonesia 17
BD - Bangladesh 14
EC - Ecuador 14
JP - Giappone 14
ZA - Sudafrica 14
AU - Australia 10
EG - Egitto 10
IQ - Iraq 10
UA - Ucraina 10
KE - Kenya 9
PK - Pakistan 9
PT - Portogallo 8
CO - Colombia 7
ES - Italia 7
RO - Romania 7
SA - Arabia Saudita 7
CL - Cile 6
PE - Perù 6
PH - Filippine 6
RU - Federazione Russa 5
UZ - Uzbekistan 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
MY - Malesia 4
NP - Nepal 4
CH - Svizzera 3
IE - Irlanda 3
LB - Libano 3
LT - Lituania 3
PY - Paraguay 3
SE - Svezia 3
TN - Tunisia 3
AT - Austria 2
AZ - Azerbaigian 2
BH - Bahrain 2
BY - Bielorussia 2
DZ - Algeria 2
ET - Etiopia 2
IR - Iran 2
JO - Giordania 2
KR - Corea 2
MD - Moldavia 2
RS - Serbia 2
SN - Senegal 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BE - Belgio 1
BF - Burkina Faso 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
FK - Isole Falkland (Malvinas) 1
GN - Guinea 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
KH - Cambogia 1
KI - Kiribati 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MA - Marocco 1
MS - Montserrat 1
MU - Mauritius 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
TW - Taiwan 1
YE - Yemen 1
Totale 8.190
Salva come PNG Salva come JPEG
Città #
San Jose 540
Singapore 432
Ashburn 349
Rome 312
Hong Kong 269
Hefei 183
Beijing 162
Boardman 91
Lauterbourg 88
Dallas 84
London 67
Shanghai 61
Ho Chi Minh City 47
Munich 39
Los Angeles 32
Council Bluffs 31
Mexico City 30
New York 29
Hanoi 24
Santa Clara 24
Amsterdam 18
Chicago 18
San Francisco 17
São Paulo 17
Brno 16
Turku 15
Boston 14
Orem 14
Pune 13
Paris 12
Warsaw 12
Washington 11
Brooklyn 10
Seattle 10
Tokyo 10
Toronto 10
Chennai 8
Lisbon 8
Montreal 8
Nairobi 8
Rio de Janeiro 8
Boydton 7
Cairo 7
Haiphong 7
Manchester 7
Redmond 7
Frankfurt am Main 6
Guangzhou 6
Johannesburg 6
Milan 6
Quito 6
Bucharest 5
Canberra 5
Guayaquil 5
Lahore 5
Riyadh 5
Buffalo 4
Charlotte 4
Curitiba 4
Da Nang 4
Helsinki 4
Kochi 4
New Delhi 4
Poplar 4
Tashkent 4
Trieste 4
Bedford 3
Belo Horizonte 3
Buenos Aires 3
Campinas 3
Curvelo 3
Dublin 3
Goiânia 3
Hangzhou 3
Helena 3
Istanbul 3
Jakarta 3
José C. Paz 3
Krasnodar 3
Lima 3
Medellín 3
Melbourne 3
Perugia 3
Phoenix 3
Rondonópolis 3
Salvador 3
Shenzhen 3
São Leopoldo 3
Taubaté 3
Ahmedabad 2
Ankara 2
Anápolis 2
Ascoli Piceno 2
Atlanta 2
Baghdad 2
Belgrade 2
Biên Hòa 2
Brasília 2
Canoas 2
Cao Lanh 2
Totale 3.372
Salva come PNG Salva come JPEG
Nome #
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 244
Management of hip fracture in the older people: rationale and design of the Italian consensus on the orthogeriatric co-management 236
Chronic cough in adults: recommendations from an Italian intersociety consensus 227
A Functional and Immunologic Point of View on Corneal Endothelial Transplantation: A Systematic Review and Meta-Analysis 226
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 221
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 218
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 213
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 207
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 206
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 203
Assessment of liver function by the exhaled breath-print during chronic liver disease 200
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 194
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 191
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 156
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 151
Orthogeriatric co-management for the care of older subjects with hip fracture: recommendations from an Italian intersociety consensus 136
Exhaled breath analysis in hepatology: State-of-the-art and perspectives 130
Gut Microbiota and Related Electronic Multisensorial System Changes in Subjects With Symptomatic Uncomplicated Diverticular Disease Undergoing Rifaximin Therapy 130
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 129
Return to Sport after Anatomic and Reverse Total Shoulder Arthroplasty in Elderly Patients: A Systematic Review and Meta-Analysis 127
A challenging alfa-fetoprotein in a cirrhotic patient 126
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 121
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 116
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 115
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 113
Authors' Reply to Brunetti et al. "Potentially Inappropriate Medications, Drug-Drug Interactions, and Anticholinergic Burden in Elderly Hospitalized Patients: Does an Association Exist with Post-Discharge Health Outcomes?" 112
ALT levels are associated with metabolic parameters and age in a large real-life population. 109
Breathprinting of liver diseases 109
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 108
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 107
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon 106
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 106
Appropriateness of direct oral anticoagulant prescribing in older subjects with atrial fibrillation discharged from acute medical wards 105
Analysis of volatile organic compounds: an innovative approach to heart failure characterization in older patients 105
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 103
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 98
Essays on quality of therapy and impact of comorbidities in older hospitalized subjects 86
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 76
Length of Hospital Stay after Total Knee Arthroplasty: A Correlation Study on 1200 Patients 74
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 66
Prevalence, risk factors, and treatment of anemia in hospitalized older patients across geriatric and nephrological settings in Italy 64
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 62
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 59
Incidence and Outcome of Pneumomediastinum in Non-ICU Hospitalized COVID-19 Patients 59
Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post-discharge health outcomes? 58
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population 56
Reply to the Letter: “Low levels of transaminase and mortality risk in older people with special reference to sarcopenia” 56
Prevalence, clinical characteristics, and disease burden of chronic cough in Italy: a cross-sectional study 54
Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey 54
Return to Sport Activity in the Elderly Patients after Unicompartmental Knee Arthroplasty: A Systematic Review and Meta-Analysis 54
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 54
Impact of Low Muscle Mass and Low Muscle Strength According to EWGSOP2 and EWGSOP1 in Community-Dwelling Older People 53
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 53
Rate of non-response to ursodeoxycholic acid in a large real-world cohort of primary biliary cholangitis patients in Italy 52
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease 50
Hepatic complications of bariatric surgery : the reverse side of the coin 50
Low Alanine Aminotransferase Levels in the Elderly Population: Frailty, Disability, Sarcopenia, and Reduced Survival 50
Preoperative and Perioperative Predictors of Length of Hospital Stay after Primary Total Hip Arthroplasty-Our Experience on 743 Cases 50
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease 50
Correction: Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey 50
Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease 49
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 48
NAFLD FIBROSIS SCORE IS ASSOCIATED WITH CARDIOVASCULAR DISEASE IN PATIENTS UNDERGOING CORONAROGRAPHY 48
Predicting risk of declining functional ability in community-dwelling older people 47
Individuation of presence and combination of genetic risk factors may help to refine the risk for most severe forms of NAFLD 47
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 46
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 46
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 46
Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis 46
Clinical outcomes and phenotypes of respiratory failure in older subjects admitted to an acute care geriatric hospital ward 45
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 44
E-nose discriminative ability within a highly homogeneous sample of respiratory diseases 44
Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank 44
Effect of sibutramine on plasma C-reactive protein, leptin and adiponectin concentrations: a systematic review and meta-analysis of randomized controlled trials 43
Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver 43
Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis 43
Screening of obstructive sleep apnea syndrome by electronic-nose analysis of volatile organic compounds 42
Sleep disorders during the COVID-19 pandemic: Results from the second phase of web-based EPICOVID19 study 41
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 41
Voltammetric analysis for distinguishing portal hypertension-related from malignancy-related ascites: A proof of concept study 41
The authors reply 41
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 40
Neurotrophic keratopathy: pros and cons of current treatments 39
Reply 38
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 38
Genetic variants in the MTHFR are not associated with fatty liver disease. 36
Microarray-based Detection of Critical Overexpressed Genes in the Progression of Hepatic Fibrosis in Non-alcoholic Fatty Liver Disease: A Protein-protein Interaction Network Analysis 35
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot 34
Liver Cirrhosis is Characterized by an Acquired Lysosomal Acid Lipase Deficiency Independent from the Etiology of Liver Disease 33
Long noncoding RNAs in nonalcoholic fatty liver disease and liver fibrosis: state-of-the-art and perspectives in diagnosis and treatment 31
Prevalence of anti-hepatitis C positivity in a nursing home: a hitherto unrecognized submerged population 30
Prevalence of patatin-like phospholipase domain containing 3 (PNPLA3) rs738409 C/G polymorphism in patients with bona-fide post-NASH cirrhosis 30
Reply 29
A noninvasive strategy for multi-disease diagnosis via multi-sensor platform: integrative analysis of five years of exhaled breath-based diagnostics for seven diseases 24
Totale 8.266
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.694
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.694
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022174 0 0 10 0 1 4 0 2 54 0 0 103
2022/202399 1 1 8 2 10 4 36 9 5 7 16 0
2023/2024316 11 27 15 36 39 120 0 10 4 16 12 26
2024/20254.616 57 25 87 19 75 96 87 25 217 291 1.633 2.004
2025/20263.061 295 148 222 344 132 202 956 214 252 296 0 0
Totale 8.266